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854-5 The  Ef fect  o f  D iabetes  on B-Type Natr luret ic  Pept ide  
Levels In Patients With Acute Dyspnea 
Alan S. Maisel, Redmila Kazanegra, James McCord, Richard M. Nowak, Judd E. 
Hollander, Phillippe Duc, Gabriel Stag, Torbjom Omland, Kathrine Wold-Knudsen, Arne 
Wsstheim, William T. Abraham, Alan B. Storrow, Alan H. Wu, Peter A. McCullough, BNP 
Multinational Study Investigators, University of California, Veterans Administration 
Medical Center, San Diego, California, University of Missouri, Truman Medical Center, 
Kansas Ci~ Missouri. 
Background. B-type natriuratic peptide (BNP) is released into the blood from ventricular 
myocytes in response to wall tension, and is reliably elevated in patients with congestive 
heart failure (CHF). Diabetes mellitus (DM) has been implicated in reduced myocardial 
compliance, and changes in the intercellular matrix of the myocardium. We sought to 
determine the effect if any, of DM on resultant BNP levels in patients presenting to the 
emergency department (ED) with acute dyspnea. 
Method=. The BNP Multinational Study was a seven-canter, prospective study of 1586 
patients who presented to the ED with acute dyspnea and had blinded BNP levels mea- 
sured with a point-of-cara device upon arrival. 
Results. Subjects reported are those with confirmed CHF 804 (55.5%) and those with 
other causes of dyspnea 644 (44.5%), primarily asthma and emphysema. A total of 
22.5% of subjects had a prior history of DM. Stratified analyses of mean BNP values for 
DM versus non-diabetiss among those with and without CHF is given in the figure. Of 
note, DM did not cause false elevations of BNP above the cutoff of 125 pg/ml. 
Conclusion, A history of DM does not impact on BNP levels measured in patients with 
acute dyspnea in the ED. Despite the many effects of DM on the cardiovascular system, 
• DM does not appear to confound BNP levels in the clinical diagnosis of CHF. 
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854-6 Evaluation of Myocardial Involvement In Duchenne 
Dystrophy Detected With Tissue Doppler Derived 
Myocardial Velocity Gradients 
Geome Koutroulis. Maria Kinali, David Dawson, Nickolaos Giatrakos, Francasco 
Muntoni, Petros Nihoyannopoulos, Hammersmith Hospital, ICSM, London, United 
Kingdom, Dubowitz Neuromuscular Centre, Hammersmith Hospital, ICSM, London, 
United Kingdom. 
Background. Duchenne muscular dystrophy (DMD) is characterized by progressive mus- 
cle weakness and wasting. Dilated cardiomyopathy with predominantly affected left ven- 
tricle, is suggested as a primary cause of death in later stages of the disease. Our 
objective was to evaluate the detection of early myocardial abnormalities in young 
patients with DMD using Tissue Doppler Imaging (TDI) derived Myocardial Velocity Gra- 
dients (MVGs). We specifically selec'ted ambulant boys with DMD, without cardiac symp- 
toms or an abnormal conventional echocerdiography study. 
Methods. Twenty eight DMD patients (mean age 8.8±2.7 years) were compared with 10 
control boys (mean age 8.6±2.6 years). From parastemal long axis (PLAX) projections, 
the end-diastolic left ventricular wall thickness of anterior septum and posterior wall, the 
end-diastolic and end-systolic left ventdcular diameter, the fractional shortening, and the 
E wave to A wave ratio (E/A) from Spectral Doppler velocities were measured. The MVG 
was measured from color M-mode TDI from the left ventricular posterior wall, and the 
analysis was performed off-line using HDI Lab ver.1.83f. The results are expressed as 
mean±SD and the differences between patients and controls were assessed by unpaired 
Student's t test. 
Results. Left ventricular posterior wall (6.18±1.52 versus 5.7±1.34 mm), anterior septum 
(6.32±1.44 versus 5.9±1.29 ram), diastolic (37.36±3.69 versus 37.5±4.24 mm) and sys- 
tolic (25.71±3.57 versus 24.8±2.49 mm) dimension, fractional shortening (31.21±5.49 
versus 33.65±4.66 %) and E/A ratio (1.9±0.4 versus 2.1±0.7) were similar between 
patients and controls. In DMD patients, MVGs were reduced during systole (1.9±0.5 ver- 
sus 3.5±0.8s-1, P<0.001), and in early diastole (3.5±0.6 versus 8.4±0.7s-1, P<0.001) 
while there were increased in late diastole (1.3±0.4 versus 0.6±0.3 s-l, P<0.001) versus 
controls. 
Conclusion. Early detection of myocardial involvement is possible with the use of MVGs 
denved from color TDI. The early diastolic MVGs appear to better characterise the dys- 
trophin deficient myocardial wall, and offer a sensitive method in the evaluation of struc- 
tural and functional changes in young, pre-symptometic DMD patients. 
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856-1 Despi te  Improv ing  Endothe l ia l  Funct ion  Oral  Vitamin C 
Increases Phosphocreatine Depletion During Exercise 
in Patients With Chronic Heart  Fai lure 
Angus K. Nightingale, Jenny G. Crilley, Nicholas C. Pegge, Rachel C. Field, Matthias 
Schmitt, Catherine Mumford, Leong Lee, Ernie A. Boehm, Doris J. Taylor, Kieren Clarke, 
Peter Styles, Michael P. Frenneau~, Wales Heart Research Institute, University of Wales 
College of Medicine, Cardiff, United Kingdom, MRC-MRS Unit, John Radcliffe Hospital, 
Oxford, United Kingdom. 
Background: It is unclear whether impaired skeletal muscle perfusion (secondary to 
endothelial dysfunction) contributes to exercise limitation in chronic heart failure (CHF). 
As endothelial function is improved by vitamin C, we hypothesized that this would 
improve skeletal muscle energetics and exercise capacity in CHF patients. 
Methods: CHF patients were randomized to treatment with vitamin C (4 g/day) (n = 19) 
or placebo (n = 18) for four weeks. Endothelial function was assessed indirectly by 
changes in pulse wave velocity (PWV) following reactive hyperemia. Incremental calf 
exercise was performed to assess skeletal muscle metabolism (phosphocreatine (PCr) 
depletion dudng exercise and resynthesis during recovery) using 31p magnetic reso- 
nance spectroscopy. 
Results: Vitamin C increased the changes in PWV following reactive hyperemia (from 
6.3 ± 0.9 % to 12.0 ± 0.8 % compared to placebo 10.4 ± 2.9 % to 7.6 ± 1.9 %; p < 0.02). 
There were no significant changes in exercise duration, or PCr recovery after exercise. 
However, in the early stages of exercise, PCr depletion was significantly increased by 
vitamin C (p < 0.05 by ANOVA) (Fig 1). 
Conclusions: Vitamin C improved large artery function in CHF. Despite this, there were 
no improvements in exercise capacity and muscle metabolism. In fact, PCr depletion was 
increased by vitamin C. This may be due to increased local nitric oxide in skeletal mus- 
cle. These data argue against endothelial dysfunction as a key determinant of exercise 
capacity in CHE 
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856-2 Phys ica l  T ra in ing  Modu la tes  P ro ln f lammatory  
Cytoklnes and Soluble Fas-Soluble Fas Ligand System 
In Patients With Chronic Heart  Fai lure 
Stamatis Adamopoulos, John T. Parissis. Dimitrios Karetzas, Chdstos Kroupis, George 
Karavolias, John Paraskevaidis, Spilios kares, Katerina koniavitou, Dimitdos T. 
Kremastinos, Onassis Cardiac Surgery Center, Athens, Greece, Amelia Fleming 
Hospital, Athens, Greece. 
Objectives: To investigate the effects of physical training on circulating proinfiammatory 
cytokines and soluble apoptosis mediators Fas (sFas) and Fas Ligand (sFasL) in 
patients with chronic heart failure (CHF). 
Background; Recent investigations have shown an overaxpression of circulating proin- 
flammatory cytokines and soluble apoptosis mediators in patients with CHF, which may 
be related tO their exercise intolerance and clinical deterioration. 
Methods: Plasma levels of tumor necrosis factor-a (TNF-a), soluble TNF receptors I and 
II (sTNF-RI and sTNF-Rtl), interleukin-6 (IL-6), soluble IL-6 receptor (slL-6R), sFas and 
sFasL were measured in 24 patients with stable CHF (New York Heart Association class 
I1-111; left ventdcutar ejection fraction: 23.2+1.3%) and in 20 normal control subjects 
before and after a 12-week program of physical training in a randomized crossover 
design. Functional status of CHF patients was evaluated by using cardiorespiratory exer- 
cise test to measure peak oxygen consumption (VO2max). 
Results: Physical training produced a significant reduction in plasma levels of TNF-a 
(7.5+1.0 vs 4.6_+0.7 pg/ml, p<0.001), sTNF-RI (3.3_+0.2 vs 2.7+0.2 ng/ml, p<0.005), 
sTNF-RII (2.6:~0.2 vs 2.3~0.2 ng/ml, p--O.06), IL-6 (8.3+1.2 vs 5.9~0.8 pg/ml, p<0.005), 
slL-6R (34.0_+3.0 vs 29.2±3.0 ng/ml, p<0.001), sFas (5.5+0.7 vs 4.5±0.8 ng/ml, p=0.05) 
and sFasL (34.9_+5.0 vs 25.2-+4.0 pg/ml, p<O.05), as well as a significant increase in 
JACC March  6 ,  2002 
vo2max (16.3t-0.7 vs 18.7t-0.8 ml/kg/min, p<0.001). Good correlations were found 
between training-induced increase in VO2max end training-induced reduction in levels of 
proinflammatory cytokine TNF-a (r=-0.54, p<0.01 ) and apoptosis inducer sFasL (r=-0.57, 
p<0.0O5) in CHF patients. On the contrary, no significant difference in circulating cytok- 
ines and apoptotic markers was found with physical training in normal subjects. 
Conclusions: Physical training reduces plasma levels of proinflammatory cytokines and 
sFas/sFasL system in patients with CHF. These immunomodulatory effects may be 
related to the training-induced improvement in functional status of CHF patients. 
11:00 a.m. 
856-3 The Oxygen Uptake Efficiency Slope as a Pred ictor  of  
Morta l i ty  in Chron ic  Heart  Failure 
A. Thomas McRae. IlL James B. Young, M. Luay AIkotob, Claire E. Pothier Snader, 
Eugene H. Blackstone, Michael S. Lauer, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: The oxygen uptake efficiency slope, defined as VO2/Iog(VE), has been 
proposed as an effort-independent measure of cardiovascular fitness. The prognostic 
value of oxygen efficiency as compared to maximum VO2 has not been assessed. 
Methods: We followed 1661 consecutive patients with chronic heart failure who were 
referred for metabolic stress testing for heart transplant evaluation. Patients were fol- 
lowed for a median of 2 years (range 0-5 years). Patients who had transplantation 
(n=t 90) were censored. 
Results: Quartile values of oxygen efficiency were 0.98+0.15, 1.31_+0.08, 1.60+0.10, 
and 2.12+0.33. Compared to patients in the highest quartile, those in the lowest quartile 
had a lower peak VO2 (10.5 vs. 23.7 ml/kg/min), were older (57 VS, 48 years), and were 
more likely to have coronary disease (54% vs. 27%). There was a strong association 
between lower oxygen efficiency and mortality (Figure) 
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(unadjusted hazard ratio [HR] of lowest to highest quartile 6.5, 95% CI 4.5 to 9.3, 
P<0.0001). In a Cox regression analysis that accounted for demographics, coronary dis- 
ease, VENcc 2 slope, and other potential confounders, oxygen efficiency was an inde- 
pendent predictor of death (adjusted HR of lowest to highest quartile 4.1, 95% CI 2.6 to 
6.5, P<0.0001), whereas maximum Vo2 was no longer predictive (adjusted HR of lowest 
to highest quartile of Vo2 1.2, 95% CI 0.5 to 3.0).Conclusion: The oxygen uptake effi- 
ciency slope is a strong and independent predictor of mortality in patients with chronic 
heart failure. 
11:15 a.rn. 
856-4 Improved Vent l la tory  Response  at Peak Exercise 
Despite No Change in Peak Oxygen Consumpt ion  With 
Chronic Beta-Blockade in Heart Failure Patients 
Euaene E. Wolfel. Tatiana O. Tsvetkova, Brain D. Lowes, JoAnn Lindenfeid, Simon F. 
Shaker, William T. Abraham, Alastair D. Robertson, Edward M. Gilbert, Michael R. 
Bristow, University of Colorado, Denver, Colorado, University of Utah, Salt Lake Ci~ 
Utah. 
Background: Although chronic beta-blockade has been shown to improve resting car- 
diac function in heart failure patients, there are minimal improvements in exercise capac- 
ity as measured by peak oxygen consumption. (PeakVO2) Recently, the ventilatory 
response to exercise, VE/VCO2, has been shown to have prognostic value in heart failure 
patients. The effect of beta-blockade on the ventilatory response to exercise is unknown. 
Methods: 26 patients with non-ischernic cardiomyopathy underwent cardiopulmonary 
exercise testing prior to and after six months of treatment with either placebo or beta- 
blockade (carvedilol or metoprolol). Peak exercise head rate, VO 2, and VENCO 2 were 
compared to baseline in each treatment group. 
Results: 
Placebo (pre) Placebo (post) Beta-Blocker (pre) Beta-Blocker (post) 
LVEF, % 24±2 28+4 20:~. 35_+2* 
Peak H R. bpm 145+4 144+~ 145:t:5 114_+4* 
Peak VO2 ml/kg/m 17.2_+1.6 16.8+1.9 15.4-+1.0 15.7±1.0 
Peak VENCO2 42.2:-+2.8 41.0+3.9 45.8+~.2 40.4_+1.5* 
(* p < 0,05) 
Conclusion: Chronic beta-blocker therapy results Jn a reduction in the excess ventilation 
with exercise in heart failure patients This reduction in VE/VCO 2 may have a favorable 
effect on both prognosis and functional capacity in heart failure patients. 
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856-5 Exercise Training Worsens Prognosis of  
Card iomyopath ic  Hamsters  (B IO14.6)v ia  Beta 1 - 
Adrenerg ic  S t imulat ion  
Issei Shiotani, Hidevuki Sato, Hiroshi Sato, Yozo Ohnishi, Eiji Hishide, Kunihiro Kinjo, 
Daisaku Nakatani, Hiroya Mizuno, Masatsugu Hod, Osaka university graduate school of 
medicine, Suite, Japan. 
Background. Although exercise training improves prognosis of ischemic heart failure, 
the effects on nonischemic heart failure are still unclear even in animal models. Because 
of metabolic bulnerability to sympathetic stimulation of failing heeds, exercise training 
may adversely affect the prognosis of nonischemic heart failure despite the beneficial 
effects on exercise capacity. To test the hypothesis, we examined the effect of exercise 
training with or without beta-blocker therapy on exercise capacity and prognosis of cardi- 
omyopathic hamsters. Methods. We assigned 87 BIO14.6 hamsters at 30 weeks of age 
into 3 groups; sedentary control group (group C, n=27 ), exercise training group ( group 
Ex, n=30 ), and exercise training plus beta-biockar group (group ExB, n=29 ). On Day 1 
of the study, baseline treadmill exercise was performed to determine the maximal run- 
ning speed at which animals could catch up. On Day 2, exercise training and medication 
were started. Treadmill exercise for 25 rain at 50% of the baseline maximal speed was 
performed on every week days for 160 days in groups Ex and ExB. In group ExB, meto- 
proiol of lmg/kg/day, a cardioselective betal-blocker, was orally administered during the 
study. To assess exercise capacity, the maximal treadmill exercise was performed on 
Day 30 and Day 90. The survival rate was assessed. Results. The maximal treadmill 
speed gradually decreased in groups C and ExB. However, the initial decrease on Day 
30 was not observed in group Ex, suggesting a short-term benefits of exercise training on 
exercise capacity. In contrast, the survival rate was lower throughout the study in group 
Ex than in group C (Kaplan-Meier, p<.005). This effect was partly but significantly attenu- 
ated in group ExB (p<.005). The survival rate on Day 160 was 70% in group C, 48% in 
group ExB, and only 33% in group Ex. Conclusion, Despite short-tarm benefits on exer- 
cise capacity, exercise training aggravated prognosis of cardiomyopathic hamsters. This 
effect was attenuated by cardioselective betal-blockade. Our results suggest that tong- 
term exercise training promotes the progression of cardiomyopathy via Betal-adrenergic 
stimulation. 
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856-6 Bra in  Natr iuret ic  PepUde Levels Predict Exercise 
Capaci ty  in Pat ients  With Chron ic  Heart  Failure 
Stefan Kruoer, Uwe Janssens, JiJrgen Graf, 33na Stickel, Karsten Filzmaier, Hugo 
Stiegler, Christian Breuer, Peter Hanrath, Medical Clinic/, University Clinic RWTH, 52057 
Aachen, Germany 
Background: Plasma levels of brain natriuretic peptide (BNP) are elevated in patients 
(pts) with chronic heart failure subject to the degree of systolic and diastolic left ventricu- 
lar dysfunction. Whether BNP levels are likewise associated with exercise capacity in pts 
with CHF is unknown. 
Methods: 70 consecutive pts with CHF (60 :I: 10 years, 19 women, LVEF 26 + 4 %) and 
10 healthy controls (55 + 16 years, 4 women, LVEF 59 + 5 %) referred for cardiopulmo- 
nary exercise testing (CPX) were prospectively studied. Resting BNP (pg/ml; immunoas- 
say, Biosite Diagnostics, San Diego, USA) was obtained after 10 minutes of supine rest 
prior to symptom-limited bicycle exercise CPX. 
Results: BNP concentrations were significantly higher in pts with CHF than in controls 
(427.6 + 377.6 vs. 24.8 + 22.1 pg/ml, p < 0.0001). In CHF pts BNP levels strongly corre- 
lated with oxygen uptake, both at anaerobic threshold (VO2AT: r = -0.54, p < 0.001) and 
maximum exercise (VO2max: r = -0.56, p < 0.001). Impairment of ventilatory efficiency 
(EqCO2: r = 0.43, p < 0.001) and maximum exercise level (watts % predicted : r = -0.44, 
p < 0.05) correlated less well with BNP. There was a significant inverse correlation 
between LVEF and BNP (r = -0.50, p < 0.05). BNP discriminated well pts with a VO2max 
< 11 ml/min/kg (Area under the ROC 0.80 + 0.09) with a criterion value of 470 pg/mL BNP 
levels > 470 pg/ml were significantly associated with VO2max < 11 ml/min/kg (risk ratio 
13.1 [95%CI 2.5-69.2]) 
Conclusions: BNP is clearly associated with exercise capacity in CHF. BNP levels show 
a significant correlation with the impairment of ventilatory efficiency and oxygen uptake at 
maximum exercise and anaerobic threshold. BNP is able to discriminate between CHF 
pts with moderately or severely impaired exercise capacity. 
